{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "East Walpole",
      "state": "MA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "63682",
      "recalling_firm": "Siemens Healthcare Diagnostics, Inc",
      "address_1": "333 Coney St",
      "address_2": "N/A",
      "postal_code": "02032-1516",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Worldwide Distribution - USA (nationwide) and Internationally to the following countries:   Argentina  Australia  Austria  Azerbaijan  Belgium  Bosnia Herzeg.  Brazil  Canada  Chile  COLOMBIA  Croatia  Czech Republic  Denmark  Egypt  Estonia  Finland  France  Germany  Greece  Hong Kong  Hungary  Iceland  India  Indonesia  Iran  Ireland  Italy  Japan  Kazakhstan  Latvia  Lithuania  Malaysia  Mexico  Netherlands  New Caledonia  Norway  Oman  P.R. China  Philippines  Poland  Portugal  Qatar  Rep. of Yemen  Republic Korea  Reunion  Romania  Russian Fed.  Saudi Arabia  Serbia  Slovakia  Slovenia  South Africa  Spain  Sweden  Switzerland  Taiwan  Thailand  Turkey  U.A.E.  United Kingdom  Uruguay  Vietnam",
      "recall_number": "Z-0506-2013",
      "product_description": "Siemens Healthcare BNP (8-type Natriuretic Peptide)  500 Test kit 02816634  100 Test 02816138     10309045, 10309044 028    Intended Use For in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur and ADVIA Centaur XP systems. This assay is indicated for the measurement of plasma BNP as an aid in the diagnosis and assessment of the severity of heart failure. In patients with acute coronary syndromes (ACS), this test, in conjunction with other known risk factors, can also be used to predict survival as well as to predict the likelihood of future heart failure.",
      "product_quantity": "100 test=24291 and 500 test= 9679",
      "reason_for_recall": "Operating range of the ADVIA Centaur systems is 18¿C to 30¿C (64.4¿F to 86.0¿F), a change in room temperature may increase or decrease assay results, depending on the specific assay and ADVIA Centaur system used.",
      "recall_initiation_date": "20121114",
      "center_classification_date": "20121211",
      "termination_date": "20150925",
      "report_date": "20121219",
      "code_info": "All lot codes"
    }
  ]
}